首页> 美国卫生研究院文献>AIMS Microbiology >Aurantiogliocladin inhibits biofilm formation at subtoxic concentrations
【2h】

Aurantiogliocladin inhibits biofilm formation at subtoxic concentrations

机译:Aurantiogliocladin在亚毒性浓度下抑制生物膜形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Infections where pathogens are organized in biofilms are difficult to treat due to increased antibiotic resistances in biofilms. To overcome this limitation new approaches are needed to control biofilms. One way is to screen natural products from organisms living in a wet environment. The rational is that these organisms are preferentially threatened by biofilm formation and may have developed strategies to control pathogens in these biofilms. In a screen of fungal isolates obtained from the Harz mountains in Germany several strains have been found producing compounds for the inhibition of biofilms. One of these strains has been identified as Clonostachys candelabrum producing aurantiogliocladin. Biological tests showed aurantiogliocladin as a weak antibiotic which was active against Staphylococcus epidermidis but not S. aureus. Aurantiogliocladin could also inhibit biofilm formation of several of the tested bacterial strains. This inhibition, however, was never complete but biofilm inhibition activity was also found at concentrations below the minimal inhibitory concentrations, e. g. Bacillus cereus with a MIC of 128 µg mL−1 showed at 32 µg mL−1 still 37% biofilm inhibition. In agreement with this finding was the observation that aurantiogliocladin was bacteriostatic for the tested bacteria but not bactericidal. Because several closely related toluquinones with different antibiotic activities have been reported from various fungi screening of a chemical library of toluquinones is suggested for the improvement of biofilm inhibition activities.
机译:由于生物膜中抗生素耐药性的增加,难以治疗在生物膜中组织有病原体的感染。为了克服该限制,需要新的方法来控制生物膜。一种方法是从生活在潮湿环境中的生物中筛选出天然产物。合理的理由是,这些生物优先受到生物膜形成的威胁,并且可能已开发出控制这些生物膜中病原体的策略。在从德国哈尔茨山获得的真菌分离株的筛选中,发现了几种菌株,这些菌株可产生抑制生物膜的化合物。这些菌株中的一种已被鉴定为能产生金葡菌素的大枝梭菌。生物学测试表明,aurantiogliocladin是一种弱抗生素,对表皮葡萄球菌有活性,但对金黄色葡萄球菌没有活性。 Aurantiogliocladin也可以抑制一些测试细菌菌株的生物膜形成。然而,这种抑制作用从未完全完成,但是在低于最小抑制浓度的浓度下,例如在10-70℃下也发现了生物膜抑制活性。 G。 MIC为128 µg mL -1 的蜡状芽孢杆菌在32 µg mL -1 的情况下仍显示37%的生物膜抑制作用。与该发现一致的是,观察到金黄色葡萄球菌素对测试的细菌具有抑菌作用,但没有杀菌作用。因为从各种真菌中已经报道了几种具有不同抗生素活性的紧密相关的甲苯醌,所以建议对甲苯醌的化学文库进行筛选以改善生物膜抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号